$3,000
total
12 months
Duration
10
Total Visits
55
Spots Remaining
About This Study
This innovative trial uses the patient's own stem cells to regenerate damaged heart tissue. Cells are harvested from bone marrow, processed, and injected directly into the heart muscle during a minimally invasive procedure.
Study Objectives
To assess improvements in heart function and exercise capacity at 6 and 12 months.
Eligibility Requirements
Inclusion Criteria
- Adults 30-75 years old
- Chronic heart failure NYHA Class II-III
- Ejection fraction between 20-40%
- Stable medical therapy for 3 months
- No recent cardiac procedures
Exclusion Criteria
- Recent heart attack (within 6 months)
- Severe valvular disease
- Active malignancy
- Implanted defibrillator contraindications
Frequently Asked Questions
Study Location
Cleveland Clinic
Cleveland, OH 44195
Map View
Research Team
Dr. David Martinez
Cleveland Clinic
Cardiovascular Research
Study Timeline
Start DateJanuary 15, 2024
End DateJuly 15, 2025
Enrollment45 / 100